Atopic dermatitis, commonly known as eczema, is a chronic skin condition that affects millions of people worldwide. Over the years, advancements in research and treatment have significantly improved the lives of those living with this condition. However, the field of dermatology is ever-evolving, and it is essential to examine how the management of atopic dermatitis
Health
Epinephrine, a widely-used medication today, was once a drug without a specific purpose. In the late 19th century, British researchers George Oliver and Edward Albert Sharpey-Schafer discovered that the extract of adrenal glands increased heart rate and blood pressure in animals. The search for the active component of adrenal extract continued, and it was ultimately
The use of high-sensitivity cardiac troponin I (hs-cTnI) testing in the emergency room for patients with hemodynamically stable pulmonary embolism (PE) has been called into question by an exploratory analysis of the PROTECT cohort study. According to this study, mild elevations in hs-cTnI did not show any prognostic value for patients with PE, unlike conventional
The field of Alzheimer’s disease research has witnessed a resurgence of interest in the development of vaccines. In recent interviews with scientists and industry professionals, it has become evident that there is a renewed focus on finding effective vaccines to combat this devastating neurological disorder. This article will delve into the latest advancements and discoveries
The use of apixaban, a direct oral anticoagulant, in children with newly diagnosed acute lymphoblastic leukemia or lymphoma did not result in a significant reduction in venous thromboembolism (VTE), according to the phase III randomized PREVAPIX-ALL study (O’Brien et al., 2021). The study found that 12% of patients receiving apixaban experienced VTE, compared to 18%
Overdoses in the United States caused by opioids have reached alarming levels, driven by the rise of high-potency synthetic opioids like fentanyl and metonitazene. Medication-assisted treatment (MAT) has proven to be a life-saving intervention, with unparalleled success in patient outcomes for individuals with opioid use disorder (OUD). This comprehensive approach combines FDA-approved medications, such as
When young medical students envision their future careers, they are faced with a multitude of considerations. Questions about personal passions, desired work hours, and financial stability often dominate these deliberations. However, I firmly believe that the most critical factor to weigh is the patient population with which a physician will work throughout their professional journey.
The recent meeting of the Pulmonary-Allergy Drugs Advisory Committee concluded with a vote of 12-1 against the approval of gefapixant for the treatment of chronic cough. This decision is based on the current evidence, which suggests that the small reductions in cough frequency observed during phase III trials do not provide a clinically meaningful benefit
Recent warnings about potentially high lead levels in recalled applesauce packets have put pediatricians on alert. While it is not yet clear if children exposed to these packets have experienced acute lead poisoning, experts advise taking the warnings seriously. According to Dr. Morri Markowitz, director of the Lead Poisoning Prevention and Treatment Program at the
The Senate Finance Healthcare Subcommittee recently held a hearing to discuss the permanent implementation of telehealth rules for the Medicare program. While there was unanimous agreement among the senators that the current flexible rules should be made permanent, the panelists themselves had differing opinions on certain aspects of telehealth. This article explores the key points